3-(3-bromopropyl)-1-benzothiophene | 34974-07-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻吩类
• 英文名称: 3-(3-bromopropyl)-1-benzothiophene
• 英文别名: 3-(bromopropyl)benzothiophene；3-(3-bromo-propyl)-benzo[b]thiophene；3-(3-Brom-propyl)-benzo[b]thiophen；3-(3-bromopropyl)-benzo[b]thiophene；3-(3-bromopropyl)benzothiophene；3-(3-Bromopropyl)benzo[b]thiophene
• CAS: 34974-07-7
• 化学式: C₁₁H₁₁BrS
• 分子量: 255.178
• InChiKey: YXRHYUGVFUYGCI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  28.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  3-(3-bromopropyl)-1-benzothiophene 在 氢氧化钾 、 乙醇 作用下， 生成 5-(benzo[b]thiophen-3-yl)pentanoic acid
  参考文献：
  名称：

  Cagniant; Cagniant, Bulletin de la Societe Chimique de France, 1952, p. 629,632

  摘要：

  DOI：
• 作为产物：
  描述：

  5-methylene-2,3,4,5-tetrahydro-1-benzothiepin 在 氢溴酸 作用下， 以 1,4-二氧六环 为溶剂， 反应 12.0h， 生成 3-(3-bromopropyl)-1-benzothiophene
  参考文献：
  名称：

  硫参与苯并噻吩衍生物侧链的构象和空间要求

  摘要：

  尝试一些苯并噻吩衍生物的扩环导致形成苯并噻吩如（3a，b）和（3d，e）。已经提出了这种转化的可能机制。

  DOI：

  10.1016/s0040-4039(01)80710-3

文献信息

• [EN] ANTIDEPRESSANT INDOLEALKYL DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXAN METHYLAMINES<br/>[FR] DERIVES INDOLEALKYLE D'HETEROCYCLE DE BENZODIOXAN FUSIONNES METHYLAMINES EN TANT QU'ANTIDEPRESSEURS
  申请人：WYETH CORP

  公开号：WO2004024734A1

  公开（公告）日：2004-03-25

  Compounds of the Formula: are useful for the treatment of depression ( including but not limited to major depressive disorder, childhood depression and dysthymia). Anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder (also known as premenstrual syndrome), attention deficit disorder ( with and without hyperactivity), obsessive compulsive disorder, social anxiety disorder, generalized anxiety disorder, obesity, eating disorders such as anorexia nervosa, bulimia nervosa, vasomotor flushing, cocaine and alcohol addiction, sexual dysfunction and related illnesses.

  这个公式的化合物对治疗抑郁症（包括但不限于重性抑郁障碍、儿童抑郁症和慢性抑郁症）非常有用。焦虑、恐慌障碍、创伤后应激障碍、经前期失调性障碍（也称为经前综合征）、注意力缺陷障碍（伴有或不伴有多动症）、强迫症、社交焦虑障碍、广泛性焦虑障碍、肥胖、厌食症、暴食症、血管运动性潮红、可卡因和酒精成瘾、性功能障碍及相关疾病均有一定疗效。
• Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
  申请人：——

  公开号：US20040138222A1

  公开（公告）日：2004-07-15

  Compounds of the formula: 1 are useful for the treatment of depression (including but not limited to major depressive disorder, childhood depression and dysthymia), anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder (also known as pre-menstrual syndrome), attention deficit disorder (with and without hyperactivity), obsessive compulsive disorder, social anxiety disorder, generalized anxiety disorder, obesity, eating disorders such as anorexia nervosa, bulimia nervosa, vasomotor flushing, cocaine and alcohol addiction, sexual dysfunction and related illnesses.

  公式1的化合物对于治疗抑郁症（包括但不限于重度抑郁症、儿童抑郁症和慢性低落情绪）、焦虑症、惊恐障碍、创伤后应激障碍、经前期不良情绪障碍（也称为经前综合征）、注意力缺陷过动症（带或不带多动症）、强迫症、社交焦虑障碍、广泛性焦虑障碍、肥胖症、饮食障碍如厌食症、贪食症、潮红、可卡因和酒精成瘾、性功能障碍以及相关疾病具有治疗作用。
• Amine compound and pharmaceutical use thereof
  申请人：Mitsubishi Tanabe Pharma Corporation

  公开号：US08129361B2

  公开（公告）日：2012-03-06

  Provided is a novel amine compound represented by the following formula (I) having a superior peripheral blood lymphocyte decreasing action and superior in the immunosuppressive action, rejection suppressive action and the like, which shows decreased side effects of, for example, bradycardia and the like, or a pharmaceutically acceptable acid addition salt thereof, or a hydrate thereof, or a solvate thereof. wherein each symbol is as defined in the specification.

  提供的是一种新型胺类化合物，其化学式如下（I），具有卓越的外周血淋巴细胞降低作用和免疫抑制作用，抗排异作用等方面表现出降低副作用的优点，例如心动过缓等，或其药学上可接受的酸盐，或其水合物，或其溶剂化物。 其中，每个符号如规范中所定义。
• Synthesis of Polycyclic Heterocycles via a One-Pot Ortho Alkylation/Direct Heteroarylation Sequence
  作者：Andrew Martins、Dino Alberico、Mark Lautens

  DOI：10.1021/ol061859+

  日期：2006.10.1

  Polycyclic thiophenes and furans were synthesized using a one-pot ortho alkylation/direct heteroarylation reaction sequence. Under the optimized reaction conditions, aryl iodides were coupled with 3-(bromoalkyl) thiophenes or -furans, affording six-and seven-membered annulated ring products via formation of two C-C bonds from two aryl C-H bonds.
• AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF
  申请人：Mitsubishi Tanabe Pharma Corporation

  公开号：EP2168944B1

  公开（公告）日：2016-05-11